A
Apotea AB (publ)
STO:APOTEA
Apotea AB (publ)
STO:APOTEA
Price:
60.48
SEK
0.25%
Market Closed
Market Cap:
kr6.5B
Relative Value
The Relative Value of one APOTEA stock under the Base Case scenario is 51.26 SEK. Compared to the current market price of 60.48 SEK, Apotea AB (publ) is Overvalued by 15%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APOTEA
Relative Value
Base Case
51.26
SEK
Overvaluation 15%
A
Multiples Across Competitors
APOTEA Competitors Multiples
Apotea AB (publ) Competitors
Apotea AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
A
|
Apotea AB (publ)
STO:APOTEA
|
6.4B SEK | 1.2 | 29.8 | 23.9 | 23.9 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
77.1B ZAR | 1.6 | 25.7 | 12.6 | 17.7 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31B ZAR | 0.8 | 26.3 | 10.6 | 16.1 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 0.1 | -1.6 | 3 | 5.1 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45.7B BRL | 1.1 | 37.3 | 12 | 21.9 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY | 1 | 32.6 | 14.2 | 21.1 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1.1T JPY | 1 | 18.9 | 8.8 | 11.2 | |
| US |
N
|
Next Generation Management Corp
OTC:NGMC
|
5.6B USD | 49.2 | -0.5 | -1.9 | -1.9 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 1.7 | 20.7 | 10.4 | 19.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30.8B CNY | 1.3 | 18.8 | 14.5 | 14.5 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 0.5 | 34.3 | 9.1 | 15.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
